Browse studies

Find your next paid study

27,370 recruiting studies available now

A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Cabotegravir Ultra Long-acting Plus Rilpivirine Ultra Long-acting or Cabotegravir Long-acting Plus Rilpivirine Long-acting in Adults and Adolescents With HIV Who Are Virologically Suppressed on ART

This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and a…

HIV Infections

Estimated

~$50 – $2,250

Actual pay is set by the research site.

ViiV HealthcareNCT07650916

The fMRI in CardiaC arrEst With Uncertain Prognosis (FACE-UP) Study

The goal of this observational study is to determine whether specific advanced MRI measures are associated with functional outcomes in patients who are comatos…

Cardiac Arrest

Estimated

~$10 – $750

Actual pay is set by the research site.

Brigham and Women's HospitalNCT06423768

Phase 3

Oral vs Intravenous Antibiotics for Treatment of Periprosthetic Joint Infection

Management of periprosthetic joint infection (PJI) commonly includes 6 weeks of intravenous (IV) antibiotics after surgical treatment. However, there is little…

Joint Infection

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Rothman Institute OrthopaedicsNCT04723940

Advancing Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning - a Prospective Study

This study is investigating the use of a computer algorithm to analyze scans of the brain before surgery to predict how a person's tumor will respond to treatm…

Glioblastoma Multiforme

Estimated

~$10 – $750

Actual pay is set by the research site.

Washington University School of MedicineNCT05864976

Phase 2

Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Tria

To learn whether certain blood and imaging tests can show which people with early-stage TNBC may already have had a complete response to chemotherapy before th…

Triple Negative Breast CancerBlood and Image GuidedOptimization of Neoadjuvant Therapy+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07610525

Phase 2

ENERGIZE: Engagement With a Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu: A Single-Center Pilot Study

The goal of this study is to test the efficacy of using a 12-week, home-based, unsupervised aerobic and resistance training exercise program for changes in can…

Metastatic Breast Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of UtahNCT07203378

Phase 1

Phase I Randomized, Double-blind Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Nucleus Basalis of Meynert or Substantia Nigra for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery

The investigators propose a Phase I single surgical-center, double-blinded randomized parallel clinical trial involving bilateral autologous peripheral nerve t…

Parkinson's Disease

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Craig van Horne, MD, PhDNCT06683378

Observational

Virtual Group Resilient Living Program For Patients Living With Advanced Cancer

This study is a prospective, minimal risk, non-randomized, single-arm study to determine feasibility and assess effectiveness of a Virtual Group Resilient Livi…

Advanced Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07659158

Observational

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States (SPINS2) Study

This research aims to investigate whether symptoms of chest pain or shortness of breath among the study population are arising due to a heart problem, particul…

Ischemic Heart Disease (IHD)Cardiac Magnetic Resonance ImagingMyocardial Blood Flow

Estimated

~$10 – $750

Actual pay is set by the research site.

Brigham and Women's HospitalNCT06854458

Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)

The SCORE-NMIBC study is a prospective, multi-center, study designed to collect data and biological samples from participants diagnosed with non-muscle Invasiv…

Non-Muscle Invasive Bladder CancerNMIBCHigh-risk Non-Muscle Invasive Bladder Cancer

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Natera, Inc.NCT07763197

Phase 1

A Phase I Study of DS-8201a in Combination With Olaparib in HER2-Expressing Malignancies

This phase I trial identifies the side effects and best dose of DS-8201a and olaparib in treating patients with HER2-expressing cancers that have spread to oth…

Metastatic Malignant Solid NeoplasmPlatinum-Resistant Ovarian High Grade Serous AdenocarcinomaUnresectable Malignant Solid Neoplasm

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT04585958

Phase 2

Pasireotide Treatment for Patients With Prolactinomas Who Need Treatment Beyond Dopamine Agonist Therapy

The researchers are doing this study to find out whether pasireotide is an effective treatment for people with prolactinoma who cannot receive dopamine agonist…

Prolactin-Producing Pituitary Tumor

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT06295952